Today’s “PDUFA: How Medicines Reach People” Lunch & Learn was an incredibly educational afternoon of conversation and connection!

Together with our partners at We Work for Health Georgia, Georgia Life Sciences, Advocates for Responsible Care, and Georgia First, we explored how scientific discoveries become treatment options and what it takes to support that progress for people living with serious illnesses. The discussion brought together perspectives from life sciences, clinical research, and patient advocacy. We examined how the Prescription Drug User Fee Act (PDUFA) supports the FDA’s ability to conduct timely, thorough reviews, along with opportunities to improve communication, reduce avoidable delays, and strengthen transparency and accountability. For the MTS Sickle Cell Foundation, it was an opportunity to bring the experiences of the sickle cell community into a broader conversation that affects so many families. Patients and caregivers have valuable insight into what meaningful treatment progress looks like, and those who participate in clinical trials make an important contribution to the options available to future patients. A shared message throughout the afternoon was the importance of bipartisan action to reauthorize PDUFA early, providing stability for the review process and the people counting on continued medical progress. Thank you to everyone who joined us and contributed their perspectives. We left with a deeper understanding of the process and an appreciation for the work we can do together to keep patients’ needs at the center. ❤️ SickleCell PatientAdvocacy ClinicalResearch PDUFAVIII